Cardiovascular News Issue 27 – October 2012

411

Highlights:

-TRILOGY-ACS shows no advantage for prasugrel over clopidogrel

-Renal denervation may be cost-effective for resistant hypertension

-German registry shows TAVI restricted to high-risk patients and with in-hospital mortality comparable to surgery

-Profile: David Holmes

 

(Visited 16 times, 1 visits today)